Navigation Links
Endologix Reports 47% Third Quarter 2009 Revenue Growth
Date:10/27/2009

IRVINE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2009.

John McDermott, Endologix President and Chief Executive Officer, said, "Our strong third quarter financial results were driven by continued sales of new products by our domestic sales force and better than expected international revenues. The launch of IntuiTrak(TM) early in 2009 was quite successful and we have received positive feedback from physicians. Our sales force is now focused on driving deeper utilization by physicians that have been introduced to this innovative delivery system and developing these new relationships into long term customers. We also continue to gradually expand our sales organization on schedule."

Mr. McDermott continued, "The international business benefitted from initial product shipments to China, an earlier than expected limited release of the IntuiTrak(TM) Delivery System in Europe and continued growth in the Japanese market. Our European distribution partners were particularly pleased to begin receiving IntuiTrak(TM), which will allow them to introduce the device to a select group of leading physicians ahead of the full product launch in 2010."

Financial Results

Total revenue in the third quarter of 2009 was $13.8 million, a 47% increase from $9.4 million in the third quarter of 2008, and a 5% increase from $13.2 million in the second quarter of 2009.

Domestic revenue was $11.3 million, a 40% increase compared with $8.1 million in the third quarter of 2008, and a 1% decrease compared with $11.4 million in the second quarter of 2009. The slight sequential decline was the result of a challenging comparison to the se
'/>"/>

SOURCE Endologix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... ATLANTA , May 1, 2015 At ... May 2-6 in Washington D.C. , ... a solution that enables clinicians to leverage the enormous ... Knife radiosurgery treatments conducted each year – to advance ... "Gamma Knife Registry is a cloud-based solution that allows ...
(Date:5/1/2015)... May 1, 2015 The Institute for Healthcare ... literacy award winners. The IHA Health Literacy Awards aim ... impact on the practice of educating or empowering organizations ... gives awards in three categories: innovative programs, published materials ... Literacy Hero award. In the area of ...
(Date:5/1/2015)... MARLBOROUGH, Mass. , May 1, 2015  Boston ... overview of its continued business momentum and long-term growth ... in New York City . President ... outline the unique opportunities the company has to bring ... into fast growing markets and deliver shareholder value. ...
Breaking Medicine Technology:Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Institute for Healthcare Advancement Announces 2015 Award Winners 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7
... 2011 Reportlinker.com announces that ... is available in its catalogue: ... Drug Safety Strategies and Risk ... clinical success ...
... FRANCISCO, Calif., Oct. 26, 2011 Onyx Pharmaceuticals, ... results from a Bayer HealthCare Pharmaceuticals Phase 3 ... for the treatment of patients with metastatic colorectal ... standard therapies. The trial met its primary endpoint ...
Cached Medicine Technology:Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 2Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 3Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 4Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 5Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 6Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 7Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 8Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 2Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 3Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 4Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 5
(Date:5/1/2015)... Ernst & Young (EY) has announced Melanie Rosenthal, ... and Burak Sezen, Co-Founder & CTO of RowdMap, Inc. ... The Year® 2015 Awards in the Ohio Valley Region ... leader in assurance, tax, transaction and advisory services and ... audit companies in the world. The awards program recognizes ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The Quail Creek ... American Cancer Society. Since 2001, the Quail Creek Relay team ... team host events throughout the year, including their biggest event, ... Golf Ball Drop. , Quail Creek Relay for Life ... battling cancer. Kate Kerwin, fitness director, states, “I was hooked ...
(Date:5/1/2015)... As the sale of legal, recreational cannabis in ... in the industry are looking back with some pride ... report by the ArcView Group , the legal ... nearly $3 billion in combined wholesale and retail sales. ... with the ongoing economic recovery, has led to a ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The frozen ... with the Hickory Crawdads (NC) and the Myrtle Beach ... have in-stadium concession locations and offer fans discounts at ... of the Hickory Community,” said Luke Shook, co-owner of ... great opportunity and we look forward to enjoying the ...
(Date:5/1/2015)... Pa. (PRWEB) May 01, 2015 Veteran Outreach ... be available to answer questions about VA Vet Centers on ... community. The MVC will be parked in front of the ... conjunction with a free screening of the documentary, “That Which ... impacts of post-traumatic stress disorder. , Please contact Robert Novotney ...
Breaking Medicine News(10 mins):Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... ... Feb. 3 The National Organization for Rare Disorders (NORD) ... will serve as media and program partners for Rare Disease Day on ... of Rare Disease Day, an event designed to call attention to the ...
... proposed by Max Kleiber in 1932, printed in biology textbooks ... in a 2000 essay in Nature as "extended to all ... wrong. "Actually, it,s two-thirds," says University of Vermont mathematician ... Physical Review Letters helps overturn almost eighty years ...
... , ... Hold Ribbon-Cutting Ceremony with Palms West Chamber of Commerce , ... (PRWEB) February 3, 2010 -- Hugs and Kisses, Inc. will be ... event kicks off with a ribbon-cutting ceremony by the Palms West Chamber of Commerce at 5:00 ...
... pedal-power brings results, study finds , WEDNESDAY, Feb. 3 (HealthDay News) ... who ride bicycles to school are in better shape than those ... of the study examined the results of physical tests and questionnaires ... in 2007 and 2008. , They found that boys who ...
... APR Energy is ... country of Haiti. The supplies will be delivered by four air- freighted shipments and are ... ... of the January 12 earthquake in Haiti, many corporations all over the world have been ...
... , , DUBLIN, Ohio , Feb. 3 ... approved a regular quarterly dividend of $0.175 per share, payable ... 1 . , This marks the 102nd consecutive regular quarterly dividend for ... Jan. 31 . , About Cardinal Health , ...
Cached Medicine News:Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 2Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 3Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 4Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 5Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 6Health News:Spherical cows help to dump metabolism law 2Health News:Spherical cows help to dump metabolism law 3Health News:Hugs and Kisses Open House To Mark The Opening Of Its New Facility 2Health News:APR Energy Launching Haiti Relief Efforts 2Health News:APR Energy Launching Haiti Relief Efforts 3Health News:APR Energy Launching Haiti Relief Efforts 4Health News:Cardinal Health Declares Regular Quarterly Dividend 2
... III, laboratory-grade pure water at a constant ... potable tap water and combine complementary purification ... is easy to operate, reliable, and allows ... a low operating cost., Applications, Glassware ...
... in our largest chest freezer, with 20.7 ... 52,700 samples -- (572) 2" boxes. Like ... utilizes ultra-thin vacuum insulation panel technology to ... Patented Tollesbury Technology improves sample preservation, reduces ...
... III, laboratory-grade pure water at a constant ... potable tap water and combine complementary purification ... is easy to operate, reliable, and allows ... a low operating cost., Applications, Glassware ...
... Premium Model U570 is an ... standards as Innova models. Comparable in ... model uses conventional cascade refrigeration and ... price point. Holds 400 2" boxes. ...
Medicine Products: